These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 27031922)

  • 1. Characterization of mAb dimers reveals predominant dimer forms common in therapeutic mAbs.
    Plath F; Ringler P; Graff-Meyer A; Stahlberg H; Lauer ME; Rufer AC; Graewert MA; Svergun D; Gellermann G; Finkler C; Stracke JO; Koulov A; Schnaible V
    MAbs; 2016 Jul; 8(5):928-40. PubMed ID: 27031922
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distinctive Low-Resolution Structural Features of Dimers of Antibody-Drug Conjugates and Parent Antibody Determined by Small-Angle X-ray Scattering.
    Law-Hine D; Rudiuk S; Bonestebe A; Ienco R; Huille S; Tribet C
    Mol Pharm; 2019 Dec; 16(12):4902-4912. PubMed ID: 31618040
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of forced degradation conditions on mAb dimer formation and subsequent influence on aggregation propensity.
    Knight MJ; Floret L; Patel N; O'Hara J; Rodriguez E
    MAbs; 2022; 14(1):2127172. PubMed ID: 36198003
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the impact of antibody fragments on aggregation of intact molecules via size exclusion chromatography coupled with native mass spectrometry.
    Xu J; Coughlin JE; Szyjka M; Jabary S; Saluja S; Sosic Z; Chen Y; Xu CF
    MAbs; 2024; 16(1):2334783. PubMed ID: 38536719
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigation of monoclonal antibody dimers in a final formulated drug by separation techniques coupled to native mass spectrometry.
    Rouby G; Tran NT; Leblanc Y; Taverna M; Bihoreau N
    MAbs; 2020; 12(1):e1781743. PubMed ID: 32633190
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure and function of purified monoclonal antibody dimers induced by different stress conditions.
    Paul R; Graff-Meyer A; Stahlberg H; Lauer ME; Rufer AC; Beck H; Briguet A; Schnaible V; Buckel T; Boeckle S
    Pharm Res; 2012 Aug; 29(8):2047-59. PubMed ID: 22477068
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural analysis of a therapeutic monoclonal antibody dimer by hydroxyl radical footprinting.
    Deperalta G; Alvarez M; Bechtel C; Dong K; McDonald R; Ling V
    MAbs; 2013; 5(1):86-101. PubMed ID: 23247543
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural Changes and Aggregation Mechanisms of Two Different Dimers of an IgG2 Monoclonal Antibody.
    Zhang J; Woods C; He F; Han M; Treuheit MJ; Volkin DB
    Biochemistry; 2018 Sep; 57(37):5466-5479. PubMed ID: 30141909
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human T cells resistant to complement lysis by bivalent antibody can be efficiently lysed by dimers of monovalent antibody.
    Nielsen SU; Routledge EG
    Blood; 2002 Dec; 100(12):4067-73. PubMed ID: 12393711
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Charge-mediated Fab-Fc interactions in an IgG1 antibody induce reversible self-association, cluster formation, and elevated viscosity.
    Arora J; Hu Y; Esfandiary R; Sathish HA; Bishop SM; Joshi SB; Middaugh CR; Volkin DB; Weis DD
    MAbs; 2016; 8(8):1561-1574. PubMed ID: 27560842
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intermolecular interactions and conformation of antibody dimers present in IgG1 biopharmaceuticals.
    Iwura T; Fukuda J; Yamazaki K; Kanamaru S; Arisaka F
    J Biochem; 2014 Jan; 155(1):63-71. PubMed ID: 24155259
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Streamlining the polishing step development process via physicochemical characterization of monoclonal antibody aggregates.
    Doss HR; Raman M; Knihtila R; Chennamsetty N; Wang D; Shupe A; Mussa N
    J Chromatogr A; 2019 Aug; 1598():101-112. PubMed ID: 30954243
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of protein cryoconcentration and processing conditions on kinetics of dimer formation for a monoclonal antibody: A case study on bioprocessing.
    Mehta SB; Subramanian S; D'Mello R; Brisbane C; Roy S
    Biotechnol Prog; 2019 Jul; 35(4):e2836. PubMed ID: 31063635
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prediction of IgG1 aggregation in solution.
    Ojala F; Degerman M; Hansen TB; Broberg Hansen E; Nilsson B
    Biotechnol J; 2014 Jun; 9(6):800-4. PubMed ID: 24760776
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Active dimer of Epratuzumab provides insight into the complex nature of an antibody aggregate.
    Remmele RL; Callahan WJ; Krishnan S; Zhou L; Bondarenko PV; Nichols AC; Kleemann GR; Pipes GD; Park S; Fodor S; Kras E; Brems DN
    J Pharm Sci; 2006 Jan; 95(1):126-45. PubMed ID: 16315222
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contributions of a disulfide bond to the structure, stability, and dimerization of human IgG1 antibody CH3 domain.
    McAuley A; Jacob J; Kolvenbach CG; Westland K; Lee HJ; Brych SR; Rehder D; Kleemann GR; Brems DN; Matsumura M
    Protein Sci; 2008 Jan; 17(1):95-106. PubMed ID: 18156469
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epitope-dependent blocking of the angiotensin-converting enzyme dimerization by monoclonal antibodies to the N-terminal domain of ACE: possible link of ACE dimerization and shedding from the cell surface.
    Kost OA; Balyasnikova IV; Chemodanova EE; Nikolskaya II; Albrecht RF; Danilov SM
    Biochemistry; 2003 Jun; 42(23):6965-76. PubMed ID: 12795591
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of monoclonal immunoglobulin a and g against shiga toxin binding subunits produced by intranasal immunization.
    Tanikawa T; Ishikawa T; Maekawa T; Kuronane K; Imai Y
    Scand J Immunol; 2008 Oct; 68(4):414-22. PubMed ID: 18782271
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigation of degradation processes in IgG1 monoclonal antibodies by limited proteolysis coupled with weak cation-exchange HPLC.
    Lau H; Pace D; Yan B; McGrath T; Smallwood S; Patel K; Park J; Park SS; Latypov RF
    J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Apr; 878(11-12):868-76. PubMed ID: 20206584
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Binding parameters and idiotypic profile of the whole immunoglobulin and Fab' fragments of murine monoclonal antibody to distinct determinants of the human high molecular weight-melanoma associated antigen.
    Temponi M; Gold AM; Ferrone S
    Cancer Res; 1992 May; 52(9):2497-503. PubMed ID: 1373670
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.